Spotlight
Money Desk
Obituaries
Classifieds
Families First
News
Weather
Specialists
Sports
Business
Opinion
Consumer
Health
Life
Out & About
Login
Program
After football on WRAL: Patchy fog to start the school year. Where your kids will be likely to see it at the bus stop.
Program
On WRAL Monday at 6: Known carcinogens hiding in your childâs classroom? WRAL Investigates why some local schools are refusing to take action
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
Gold
Crude Oil
Local Stocks
WRALTechWire 30
WRALTechWire 30
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Voyager Therapeut
(NQ:
VYGR
)
6.800
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Voyager Therapeut
< Previous
1
2
3
4
5
6
Next >
Voyager Therapeutics' Seasoned Management And Leading Adeno-Associated Virus Capsid Platform Impress Bullish Analyst
May 10, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For May 10, 2023
May 10, 2023
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
May 09, 2023
Via
Benzinga
McKesson, ICU Medical, Novavax And Other Big Stocks Moving Higher On Tuesday
May 09, 2023
U.S. stocks traded lower, with the Dow Jones dropping around 50 points on Tuesday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
Earnings Preview For Voyager Therapeutics
May 08, 2023
Via
Benzinga
Why PRA Group Shares Are Trading Lower By 44%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
May 09, 2023
Gainers TScan Therapeutics, Inc. (NASDAQ: TCRX) shares gained 118% to $4.68 after the company and Amgen announced collaboration to identify novel targets in Crohn's disease.
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 10, 2023
March 10, 2023
Via
Benzinga
Earnings Outlook For Voyager Therapeutics
March 06, 2023
Via
Benzinga
Earnings Scheduled For May 9, 2023
May 09, 2023
Companies Reporting Before The Bell • Kosmos Energy (NYSE:KOS) is expected to report quarterly earnings at $0.17 per share on revenue of $440.16 million.
Via
Benzinga
$39M Bet On This Biotechnology Stock? Check Out These 3 Stocks Insiders Are Buying
February 27, 2023
Although US stocks closed lower on Friday, there were a few notable insider trades.
Via
Benzinga
Why Voyager Therapeutics Stock Is Sinking This Week
January 20, 2023
Investors are taking profits on this red-hot stock this week.
Via
The Motley Fool
Voyager Therapeutics' TRACER Capsids Show Encouraging Action In Animal Models
May 19, 2022
Via
Benzinga
7 A-Rated Stocks to Buy for Less Than $25
January 24, 2023
These seven stocks to buy for less than $25 per share are strong opportunities in today's resilient yet uncertain market.
Via
InvestorPlace
Stock Market Rally Gains Steam As Inflation Cools; Tesla Price Cuts, Big Earnings In Focus: Weekly Review
January 13, 2023
Sharp Tesla price cuts and some notable earnings were in focus.
Via
Investor's Business Daily
National Instruments, Virgin Galactic And Other Big Stocks Moving Higher On Friday
January 13, 2023
U.S. stocks traded slightly higher, with the Dow Jones gaining around 25 points on Friday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
Why Is Apexigen (APGN) Stock Up 97% Today?
January 09, 2023
Apexigen (APGN) stock is rocketing higher on Monday following new coverage of the company from an analyst and heavy trading.
Via
InvestorPlace
Why Is Party City (PRTY) Stock Up 41% Today?
January 09, 2023
Party City (PRTY) stock is in the news Monday as investors prepare for the celebration goods company to file for bankruptcy.
Via
InvestorPlace
Voyager Therapeutics (VYGR) Stock Gains 18% on Gene Therapy Deal
January 09, 2023
Voyager Therapeutics' lucrative arrangement with a fellow biotech business is putting VYGR stock traders in a buying mood today.
Via
InvestorPlace
Neurocrine Biosciences, Voyager Therapeutics Collaborate For Neurological-Focused Gene Therapies
January 09, 2023
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
January 09, 2023
Via
Benzinga
Earnings Scheduled For November 8, 2022
November 08, 2022
Companies Reporting Before The Bell • Adtran (NASDAQ:ADTN) is likely to report quarterly earnings at $0.18 per share on revenue of $330.39 million.
Via
Benzinga
Voyager Therapeutics's Earnings Outlook
November 07, 2022
Voyager Therapeutics (NASDAQ:VYGR) is set to give its latest quarterly earnings report on Tuesday, 2022-11-08. Here's what investors need to know before the announcement. Analysts estimate that Voyager...
Via
Benzinga
Pfizer In-Licenses Voyager Therapeutics' AAV Capsid For Rare Neurologic Disease Target
October 04, 2022
Via
Benzinga
7 Top-Rated Biotech Stocks to Buy for Q4
September 15, 2022
A new White House program makes these seven names some outstanding biotech stocks to buy for the fourth quarter.
Via
InvestorPlace
Voyager Therapeutics Prioritizes Pipeline With Cash Runway Into 2024
August 05, 2022
Via
Benzinga
Biotech Daily: Amgen, Gilead Go Shopping, Nod For AstraZeneca's Lynparza In Early Stage Breast Cancer, Decision Day For Alzheimer's Associated Hallucinations Candidate
August 04, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
The Daily Biotech Pulse: European Backing For Novavax's COVID-19 Shot In Adolescents, Sanofi-GSK's Updated Vaccine Effective Against Omicron, FDA's Clinical Hold On Sarepta's Duchenne Trial
June 24, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
95 Biggest Movers From Yesterday
June 07, 2022
Gainers AeroClean Technologies, Inc. (NASDAQ: AERC) shares gained 100.4% to close at $4.75 on Monday after the FDA granted clearance for the company's pūrgo technology, classifying it as a class II...
Via
Benzinga
The Daily Biotech Pulse: Valneva's COVID-19 Vaccine Filing Accepted By EMA, Enanta's RSV Candidate Fails, Orphan Drug Tag For Mersana's Gastric Cancer Candidate
May 19, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
83 Biggest Movers From Yesterday
May 06, 2022
Gainers Hudson Technologies, Inc. (NASDAQ: HDSN) shares jumped 26.9% to close at $9.06 on Thursday after the company reported better-than-expected Q1 EPS and sales results.
Via
Benzinga
< Previous
1
2
3
4
5
6
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.